Dolutegravir 25 mg and 50 mg and Sandostatin LAR
Determining the interaction of Dolutegravir 25 mg and 50 mg and Sandostatin LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Sandostatin LAR Depot
- Dolutegravir 25 mg and 50 mg-Sandostatin LAR Depot injection
- Dolutegravir 25 mg and 50 mg-Sani-Supp
- Dolutegravir 25 mg and 50 mg-Sani-Supp rectal
- Dolutegravir 25 mg and 50 mg-Sansert
- Dolutegravir 25 mg and 50 mg-Santyl
- Sandostatin LAR-Dolutegravir and lamivudine
- Sandostatin LAR-Dolutegravir and rilpivirine
- Sandostatin LAR-Dolutegravir Sodium
- Sandostatin LAR-Dolutegravir Sodium And Lamivudine
- Sandostatin LAR-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Sandostatin LAR-Dom-Etoposide